MacroGenics | MGNX - Ebit

Stock Price
4.25
Daily Change
0.09 2.16%
Monthly
24.63%
Yearly
168.99%
Q2 Forecast
4.16

MacroGenics reported $-12.1M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Amgen USD 3.83B 130M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Biogen USD 514.3M 502.8M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Genmab DKK 260M 199M Dec/2025
Geron USD -236K 10.55M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
MacroGenics USD -12.1M 32.26M Dec/2025
Merck USD -1.88B 8.12B Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Puma Biotechnology USD -2.2M 11.41M Jun/2024
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Xencor USD -77.86M 24.23M Mar/2026